Nutraveris
Wednesday, June 18, 2014
Category : Non classé | Author : experts
Tags:

Following case reports (Nutrivigilance system) and suspicions of falsification in eye health food supplements, the DGCCRF conducted in 2012 a survey on these products. An information note published in March 2014 summarizes the findings of this investigation.
Especially 50 % of controlled products contained meso-zeaxanthin, a synthetic isomer of zeaxanthin. DGCCRF considers that meso-zeaxanthin is in the scope if Regulation (EC) N° 258/97 concerning novel foods and novel food ingredients and therefore can not be used for human consumption without prior authorization. According to the analytical results, the presence of meso-zeaxanthin would be due to the manufacturing process of the extract of Tagetes erecta concentrating zeaxanthin (saponification of lutein esters at high temperature producing a concentrate of zeaxanthin, achieved in part through the use of a solvent which is not allowed by Directive 2009/32/EC, dimethyl sulfoxide (DMSO)).

Following case reports (Nutrivigilance system) and suspicions of falsification in eye health food supplements, the DGCCRF conducted in 2012 a survey on these products. An information note published in March 2014 summarizes the findings of this investigation.Especially 50 % of controlled products contained meso-zeaxanthin, a synthetic isomer of zeaxanthin. DGCCRF considers that meso-zeaxanthin is in the scope if Regulation (EC) N° 258/97 concerning novel foods and novel food ingredients and therefore can not be used for human consumption without prior authorization. According to the analytical results, the presence of meso-zeaxanthin would be due to the manufacturing process of the extract of Tagetes erecta concentrating zeaxanthin (saponification of lutein esters at high temperature producing a concentrate of zeaxanthin, achieved in part through the use of a solvent which is not allowed by Directive 2009/32/EC, dimethyl sulfoxide (DMSO)).

Leave a Reply